Lee, K. ., , & Choi, H. . (2018). Gliclazide, a K<sub>ATP</sub> channel blocker, inhibits vascular smooth muscle cell proliferation through the CaMKKβ-AMPK pathway. Vascular Pharmacology. https://doi.org/10.1016/j.vph.2018.01.001 (Original work published 2018)
